Decades after the cooperative study: A re-examination of systemic blood pressure in sickle cell disease

American Journal of Hematology

Volumn 87, Issue 10, 2012, Pages

  Desai, Payal C ^a   Deal, Allison M ^b   Brittain, Julia E ^a   Jones, Susan ^a   Hinderliter, Alan ^a   Ataga, Kenneth I ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BILIRUBIN; BILIRUBIN GLUCURONIDE; CREATININE; ENDOTHELIN 1; HEMOGLOBIN; HEMOGLOBIN F; HYDROXYUREA; LACTATE DEHYDROGENASE; PLACENTAL GROWTH FACTOR; PROTEIN; PROTEIN TYROSINE KINASE; SOLUBLE FMS LIKE TYROSINE KINASE 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE CHEST SYNDROME; ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; BETA THALASSEMIA; BILIRUBIN BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LACTATE DEHYDROGENASE BLOOD LEVEL; LETTER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MONOCYTE; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RETICULOCYTE COUNT; RETINOPATHY; SICKLE CELL ANEMIA; SMOKING; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANEMIA, SICKLE CELL; BILIRUBIN; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; DIASTOLE; FEMALE; GENOTYPE; HUMANS; HYDROXYUREA; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; NORTH CAROLINA; SICKLE CELL TRAIT; STROKE; SYSTOLE; THALASSEMIA; YOUNG ADULT;

EID: 84866774622     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23278     Document Type: Letter

References (27)

1. de Jong PE, Landman H, van Eps LW. Blood pressure in sickle cell disease. Arch Intern Med 1982; 142: 1239-1240.
2. Grell GA, Alleyne GA, Serjeant GR. Blood pressure in adults with homozygous sickle cell disease. Lancet 1981; 2: 1166.
3. Johnson CS, Giorgio AJ. Arterial blood pressure in adults with sickle cell disease. Arch Intern Med 1981; 141: 891-893.
4. Pegelow CH, Colangelo L, Steinberg M, Wright EC, Smith J, Phillips G, Vichinsky E. Natural history of blood pressure in sickle cell disease: Risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med 1997; 102: 171-177.
5. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 1998; 91: 288-294.
6. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004; 350: 886-895.
7. Guasch A, Cua M, Mitch WE. Early detection and the course of glomerular injury in patients with sickle cell anemia. Kidney Int 1996; 49: 786-791.
8. Thompson J, Reid M, Hambleton I, et al. Albuminuria and renal function in homozygous sickle cell disease: observations from a cohort study. Arch Int Med 2007; 167: 701-708.
9. Dyer AR, Elliott P. The INTERSALT study: Relations of body mass index to blood pressure. INTERSALT Co-operative Research Group. J Hum Hypertens 1989; 3: 299-308.
10. Hatch FE, Crowe LR, Miles DE, et al. Altered vascular reactivity in sickle hemoglobinopathy. A possible protective factor from hypertension. Am J Hypertens 1989; 2: 2-8.
11. Cochran RTJr. Hyposthenuria in sickle cell states. Arch Int Med 1963; 112: 222-225.
12. Oguanobi NI, Onwubere BJC, Ibegbulam OG. Arterial blood pressure in adult Nigerians with sickle cell anemia. J Cardiol 2010; 56: 326-331.
13. Brittain JE, Hulkower B, Jones SK, et al. Placenta growth factor in sickle cell disease: Association with hemolysis and inflammation. Blood 2010; 115: 2014-2020.
14. Teixeira PG, Cabral AC, Andrade SP, et al. Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension. Hypertens Pregnancy 2008; 27: 65-73.
15. 3-dependent iNOS expression in the vasculature of healthy mice. Blood 2008; 111: 5187-5194.
16. Platt OS. Sickle cell anemia as an inflammatory disease. J Clin Invest 2000; 106: 337-338.
17. Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation 2004; 11: 129-151.
18. Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: Incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994; 84: 643-649.
19. Frenette PS. Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion. Microcirculation 2004; 11: 167-177.
20. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-1644.
21. Ataga KI, Brittain JE, Desai P, et al. Association of coagulation activation with clinical complications in sickle cell sisease. PLoS ONE 2012; 7: e29786.
22. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. N Engl J Med 1991; 325: 11-16.
23. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000; 342: 1855-1865.
24. Ataga KI, Moore CG, Jones S, et al. Pulmonary hypertension in patients with sickle cell disease: A longitudinal study. Br J Haematol 2006; 134: 109-115.
25. Reinders A, Reggiori F, Shennan AH. Validation of the DINAMAP ProCare blood pressure device according to the international protocol in an adult population. Blood Press Monit 2006; 11: 293-296.
26. de Greeff A, Reggiori F, Shennan AH. Clinical assessment of the DINAMAP ProCare monitor in an adult population according to the British Hypertension Society Protocol. Blood Press Monit 2007; 12: 51-55.
27. Gaston M, Rosse WF. The cooperative study of sickle cell disease: Review of study design and objectives. Am J Pediatr Hematol Oncol 1982; 4: 197-201.